{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/alzamend-neuro-reports-positive-topline-data-from-phase-ii-clinical-trial-of-al001-lithium-in-brain-study-al001-achieves-bioequivalence-and-demonstrates-superior-brain-delivery-across-all-measured-brain-regions-302725991.html", "message": "News view counter 625255 successfully enlarged"}